Vildagliptin (Galvus)

vildagliptin · Novartis

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Vildagliptin (Galvus), covering 2012-05-07 to 2025-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia [Phase 2]